KUALA LUMPUR: Mah Sing Group Bhd
has received 99.996 per cent shareholders’ approval for its proposed diversification into glove manufacturing and trading, and related healthcare products via Mah Sing Healthcare Sdn Bhd.
It said the first six production lines at Mah Sing’s first glove manufacturing factory in Kapar, Klang would be operational as planned in the second quarter of 2021, followed by another six lines expected to be ready in the third quarter, with a total maximum capacity of up to 3.68 billion pieces of gloves per annum.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
